SEC 13F Intelligence

Corton Capital Inc. / CORT

Corton Capital Inc.’s Corcept Therapeutics Inc Position

Does Corton Capital Inc. own Corcept Therapeutics Inc (CORT)? Not currently — the last reported position was 2.7K shares worth $305,196 in Q1 2025; the fund’s latest 13F (Q3 2025) no longer reports it.

Position Value
$305,196
Q1 2025
Shares
2.7K
% of Portfolio
+1.01%
Quarters Held
5
position exited

Position History CORT

Reported value by quarter
Q4 ’23: $287,318Q4 ’23Q1 ’24: $429,615Q1 ’24Q2 ’24: $379,548Q2 ’24Q4 ’24: $297,503Q4 ’24Q1 ’25: $305,196Q1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20252.7K$305,196+1.01%
Q4 20245.9K$297,503+0.17%
Q2 202411.7K$379,548+0.20%
Q1 202417.1K$429,615+0.16%
Q4 20238.8K$287,318+0.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Corton Capital Inc.’s full portfolio or all institutional holders of CORT.